Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Restless Legs Syndrome Market Size Growth Rate by Type (2014-2025) 1.4.2 Pharmacological Therapy 1.4.3 Non-Pharmacological Therapy 1.5 Market by Application 1.5.1 Global Restless Legs Syndrome Market Share by Application (2014-2025) 1.5.2 < 35 Years Old 1.5.3 35-50 Years Old 1.5.4 > 50 Years Old 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Restless Legs Syndrome Market Size 2.2 Restless Legs Syndrome Growth Trends by Regions 2.2.1 Restless Legs Syndrome Market Size by Regions (2014-2025) 2.2.2 Restless Legs Syndrome Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Restless Legs Syndrome Market Size by Manufacturers 3.1.1 Global Restless Legs Syndrome Revenue by Manufacturers (2014-2019) 3.1.2 Global Restless Legs Syndrome Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Restless Legs Syndrome Market Concentration Ratio (CR5 and HHI) 3.2 Restless Legs Syndrome Key Players Head office and Area Served 3.3 Key Players Restless Legs Syndrome Product/Solution/Service 3.4 Date of Enter into Restless Legs Syndrome Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Restless Legs Syndrome Market Size by Type (2014-2019) 4.2 Global Restless Legs Syndrome Market Size by Application (2014-2019) 5 United States 5.1 United States Restless Legs Syndrome Market Size (2014-2019) 5.2 Restless Legs Syndrome Key Players in United States 5.3 United States Restless Legs Syndrome Market Size by Type 5.4 United States Restless Legs Syndrome Market Size by Application 6 Europe 6.1 Europe Restless Legs Syndrome Market Size (2014-2019) 6.2 Restless Legs Syndrome Key Players in Europe 6.3 Europe Restless Legs Syndrome Market Size by Type 6.4 Europe Restless Legs Syndrome Market Size by Application 7 China 7.1 China Restless Legs Syndrome Market Size (2014-2019) 7.2 Restless Legs Syndrome Key Players in China 7.3 China Restless Legs Syndrome Market Size by Type 7.4 China Restless Legs Syndrome Market Size by Application 8 Japan 8.1 Japan Restless Legs Syndrome Market Size (2014-2019) 8.2 Restless Legs Syndrome Key Players in Japan 8.3 Japan Restless Legs Syndrome Market Size by Type 8.4 Japan Restless Legs Syndrome Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Restless Legs Syndrome Market Size (2014-2019) 9.2 Restless Legs Syndrome Key Players in Southeast Asia 9.3 Southeast Asia Restless Legs Syndrome Market Size by Type 9.4 Southeast Asia Restless Legs Syndrome Market Size by Application 10 India 10.1 India Restless Legs Syndrome Market Size (2014-2019) 10.2 Restless Legs Syndrome Key Players in India 10.3 India Restless Legs Syndrome Market Size by Type 10.4 India Restless Legs Syndrome Market Size by Application 11 Central & South America 11.1 Central & South America Restless Legs Syndrome Market Size (2014-2019) 11.2 Restless Legs Syndrome Key Players in Central & South America 11.3 Central & South America Restless Legs Syndrome Market Size by Type 11.4 Central & South America Restless Legs Syndrome Market Size by Application 12 International Players Profiles 12.1 GlaxoSmithKline plc. 12.1.1 GlaxoSmithKline plc. Company Details 12.1.2 Company Description and Business Overview 12.1.3 Restless Legs Syndrome Introduction 12.1.4 GlaxoSmithKline plc. Revenue in Restless Legs Syndrome Business (2014-2019) 12.1.5 GlaxoSmithKline plc. Recent Development 12.2 Ligand Pharmaceuticals Incorporated 12.2.1 Ligand Pharmaceuticals Incorporated Company Details 12.2.2 Company Description and Business Overview 12.2.3 Restless Legs Syndrome Introduction 12.2.4 Ligand Pharmaceuticals Incorporated Revenue in Restless Legs Syndrome Business (2014-2019) 12.2.5 Ligand Pharmaceuticals Incorporated Recent Development 12.3 axxonis Pharma AG 12.3.1 axxonis Pharma AG Company Details 12.3.2 Company Description and Business Overview 12.3.3 Restless Legs Syndrome Introduction 12.3.4 axxonis Pharma AG Revenue in Restless Legs Syndrome Business (2014-2019) 12.3.5 axxonis Pharma AG Recent Development 12.4 Kyowa Hakko Kirin 12.4.1 Kyowa Hakko Kirin Company Details 12.4.2 Company Description and Business Overview 12.4.3 Restless Legs Syndrome Introduction 12.4.4 Kyowa Hakko Kirin Revenue in Restless Legs Syndrome Business (2014-2019) 12.4.5 Kyowa Hakko Kirin Recent Development 12.5 Jazz Pharmaceuticals 12.5.1 Jazz Pharmaceuticals Company Details 12.5.2 Company Description and Business Overview 12.5.3 Restless Legs Syndrome Introduction 12.5.4 Jazz Pharmaceuticals Revenue in Restless Legs Syndrome Business (2014-2019) 12.5.5 Jazz Pharmaceuticals Recent Development 12.6 Omeros Corporation 12.6.1 Omeros Corporation Company Details 12.6.2 Company Description and Business Overview 12.6.3 Restless Legs Syndrome Introduction 12.6.4 Omeros Corporation Revenue in Restless Legs Syndrome Business (2014-2019) 12.6.5 Omeros Corporation Recent Development 12.7 Manhattan Pharmaceuticals 12.7.1 Manhattan Pharmaceuticals Company Details 12.7.2 Company Description and Business Overview 12.7.3 Restless Legs Syndrome Introduction 12.7.4 Manhattan Pharmaceuticals Revenue in Restless Legs Syndrome Business (2014-2019) 12.7.5 Manhattan Pharmaceuticals Recent Development 12.8 Boehringer Ingelheim GmbH 12.8.1 Boehringer Ingelheim GmbH Company Details 12.8.2 Company Description and Business Overview 12.8.3 Restless Legs Syndrome Introduction 12.8.4 Boehringer Ingelheim GmbH Revenue in Restless Legs Syndrome Business (2014-2019) 12.8.5 Boehringer Ingelheim GmbH Recent Development 12.9 UCB SA 12.9.1 UCB SA Company Details 12.9.2 Company Description and Business Overview 12.9.3 Restless Legs Syndrome Introduction 12.9.4 UCB SA Revenue in Restless Legs Syndrome Business (2014-2019) 12.9.5 UCB SA Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Restless Legs Syndrome Key Market Segments Table Key Players Restless Legs Syndrome Covered Table Global Restless Legs Syndrome Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Restless Legs Syndrome Market Size Market Share by Type 2014-2025 Figure Pharmacological Therapy Figures Table Key Players of Pharmacological Therapy Figure Non-Pharmacological Therapy Figures Table Key Players of Non-Pharmacological Therapy Table Global Restless Legs Syndrome Market Size Growth by Application 2014-2025 (Million US$) Figure < 35 Years Old Case Studies Figure 35-50 Years Old Case Studies Figure > 50 Years Old Case Studies Figure Restless Legs Syndrome Report Years Considered Table Global Restless Legs Syndrome Market Size 2014-2025 (Million US$) Figure Global Restless Legs Syndrome Market Size and Growth Rate 2014-2025 (Million US$) Table Global Restless Legs Syndrome Market Size by Regions 2014-2025 (Million US$) Table Global Restless Legs Syndrome Market Size by Regions 2014-2019 (Million US$) Table Global Restless Legs Syndrome Market Share by Regions 2014-2019 Figure Global Restless Legs Syndrome Market Share by Regions 2014-2019 Figure Global Restless Legs Syndrome Market Share by Regions 2019 Table Market Top Trends Table Global Restless Legs Syndrome Revenue by Manufacturers (2014-2019) (Million US$) Table Global Restless Legs Syndrome Market Share by Manufacturers (2014-2019) Figure Global Restless Legs Syndrome Market Share by Manufacturers in 2018 Table Global Restless Legs Syndrome Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Restless Legs Syndrome Product/Solution/Service Table Date of Enter into Restless Legs Syndrome Market Table Mergers & Acquisitions, Expansion Plans Table Global Restless Legs Syndrome Market Size by Type (2014-2019) (Million US$) Table Global Restless Legs Syndrome Market Size Share by Type (2014-2019) Figure Global Restless Legs Syndrome Market Size Market Share by Type (2014-2019) Table Global Restless Legs Syndrome Market Size by Application (2014-2019) (Million US$) Table Global Restless Legs Syndrome Market Size Share by Application (2014-2019) Figure Global Restless Legs Syndrome Market Size Market Share by Application (2014-2019) Figure Global Restless Legs Syndrome Revenue Market Share by Application in 2018 Figure United States Restless Legs Syndrome Market Size 2014-2019 (Million US$) Table United States Key Players Restless Legs Syndrome Revenue (2018-2019) (Million US$) Table United States Key Players Restless Legs Syndrome Market Share (2018-2019) Table United States Restless Legs Syndrome Market Size by Type (2014-2019) (Million US$) Table United States Restless Legs Syndrome Market Share by Type (2014-2019) Table United States Restless Legs Syndrome Market Size by Application (2014-2019) (Million US$) Table United States Restless Legs Syndrome Market Share by Application (2014-2019) Figure Europe Restless Legs Syndrome Market Size 2014-2019 (Million US$) Table Europe Key Players Restless Legs Syndrome Revenue (2018-2019) (Million US$) Table Europe Key Players Restless Legs Syndrome Market Share (2018-2019) Table Europe Restless Legs Syndrome Market Size by Type (2014-2019) (Million US$) Table Europe Restless Legs Syndrome Market Share by Type (2014-2019) Table Europe Restless Legs Syndrome Market Size by Application (2014-2019) (Million US$) Table Europe Restless Legs Syndrome Market Share by Application (2014-2019) Figure China Restless Legs Syndrome Market Size 2014-2019 (Million US$) Table China Key Players Restless Legs Syndrome Revenue (2018-2019) (Million US$) Table China Key Players Restless Legs Syndrome Market Share (2018-2019) Table China Restless Legs Syndrome Market Size by Type (2014-20189) (Million US$) Table China Restless Legs Syndrome Market Share by Type (2014-2019) Table China Restless Legs Syndrome Market Size by Application (2014-2019) (Million US$) Table China Restless Legs Syndrome Market Share by Application (2014-2019) Figure Japan Restless Legs Syndrome Market Size 2014-2019 (Million US$) Table Japan Key Players Restless Legs Syndrome Revenue (2018-2019) (Million US$) Table Japan Key Players Restless Legs Syndrome Market Share (2018-2019) Table Japan Restless Legs Syndrome Market Size by Type (2014-2019) (Million US$) Table Japan Restless Legs Syndrome Market Share by Type (2014-2019) Table Japan Restless Legs Syndrome Market Size by Application (2014-2019) (Million US$) Table Japan Restless Legs Syndrome Market Share by Application (2014-2019) Figure Southeast Asia Restless Legs Syndrome Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Restless Legs Syndrome Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Restless Legs Syndrome Market Share (2018-2019) Table Southeast Asia Restless Legs Syndrome Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Restless Legs Syndrome Market Share by Type (2014-2019) Table Southeast Asia Restless Legs Syndrome Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Restless Legs Syndrome Market Share by Application (2014-2019) Figure India Restless Legs Syndrome Market Size 2014-2019 (Million US$) Table India Key Players Restless Legs Syndrome Revenue (2018-2019) (Million US$) Table India Key Players Restless Legs Syndrome Market Share (2018-2019) Table India Restless Legs Syndrome Market Size by Type (2014-2019) (Million US$) Table India Restless Legs Syndrome Market Share by Type (2014-2019) Table India Restless Legs Syndrome Market Size by Application (2014-2019) (Million US$) Table India Restless Legs Syndrome Market Share by Application (2014-2019) Figure Central & South America Restless Legs Syndrome Market Size 2014-2019 (Million US$) Table Central & South America Key Players Restless Legs Syndrome Revenue (2018-2019) (Million US$) Table Central & South America Key Players Restless Legs Syndrome Market Share (2018-2019) Table Central & South America Restless Legs Syndrome Market Size by Type (2014-2019) (Million US$) Table Central & South America Restless Legs Syndrome Market Share by Type (2014-2019) Table Central & South America Restless Legs Syndrome Market Size by Application (2014-2019) (Million US$) Table Central & South America Restless Legs Syndrome Market Share by Application (2014-2019) Table GlaxoSmithKline plc. Company Details Table GlaxoSmithKline plc. Revenue in Restless Legs Syndrome Business (2014-2019) (Million US$) Figure GlaxoSmithKline plc. Revenue Growth Rate in Restless Legs Syndrome Business (2014-2019) Table GlaxoSmithKline plc. Recent Development Table Ligand Pharmaceuticals Incorporated Company Details Table Ligand Pharmaceuticals Incorporated Revenue in Restless Legs Syndrome Business (2014-2019)(Million US$) Figure Ligand Pharmaceuticals Incorporated Revenue Growth Rate in Restless Legs Syndrome Business (2014-2019) Table Ligand Pharmaceuticals Incorporated Recent Development Table axxonis Pharma AG Company Details Table axxonis Pharma AG Revenue in Restless Legs Syndrome Business (2014-2019)(Million US$) Figure axxonis Pharma AG Revenue Growth Rate in Restless Legs Syndrome Business (2014-2019) Table axxonis Pharma AG Recent Development Table Kyowa Hakko Kirin Company Details Table Kyowa Hakko Kirin Revenue in Restless Legs Syndrome Business (2014-2019)(Million US$) Figure Kyowa Hakko Kirin Revenue Growth Rate in Restless Legs Syndrome Business (2014-2019) Table Kyowa Hakko Kirin Recent Development Table Jazz Pharmaceuticals Company Details Table Jazz Pharmaceuticals Revenue in Restless Legs Syndrome Business (2014-2019)(Million US$) Figure Jazz Pharmaceuticals Revenue Growth Rate in Restless Legs Syndrome Business (2014-2019) Table Jazz Pharmaceuticals Recent Development Table Omeros Corporation Company Details Table Omeros Corporation Revenue in Restless Legs Syndrome Business (2014-2019)(Million US$) Figure Omeros Corporation Revenue Growth Rate in Restless Legs Syndrome Business (2014-2019) Table Omeros Corporation Recent Development Table Manhattan Pharmaceuticals Company Details Table Manhattan Pharmaceuticals Revenue in Restless Legs Syndrome Business (2014-2019)(Million US$) Figure Manhattan Pharmaceuticals Revenue Growth Rate in Restless Legs Syndrome Business (2014-2019) Table Manhattan Pharmaceuticals Recent Development Table Boehringer Ingelheim GmbH Company Details Table Boehringer Ingelheim GmbH Revenue in Restless Legs Syndrome Business (2014-2019)(Million US$) Figure Boehringer Ingelheim GmbH Revenue Growth Rate in Restless Legs Syndrome Business (2014-2019) Table Boehringer Ingelheim GmbH Recent Development Table UCB SA Company Details Table UCB SA Revenue in Restless Legs Syndrome Business (2014-2019)(Million US$) Figure UCB SA Revenue Growth Rate in Restless Legs Syndrome Business (2014-2019) Table UCB SA Recent Development Table Global Restless Legs Syndrome Market Size by Regions (Million US$) 2019-2025 Figure Global Restless Legs Syndrome Market Size Share by Regions (2019-2025) Figure Global Restless Legs Syndrome Market Size Share by Regions in 2025 Figure United States Restless Legs Syndrome Market Size Forecast (2019-2025)(Million USD) Figure Europe Restless Legs Syndrome Market Size Forecast (2019-2025)(Million USD) Figure China Restless Legs Syndrome Market Size Forecast (2019-2025)(Million USD) Figure Japan Restless Legs Syndrome Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Restless Legs Syndrome Market Size Forecast (2019-2025)(Million USD) Figure India Restless Legs Syndrome Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Restless Legs Syndrome Market Size Forecast (2019-2025)(Million USD) Table Global Restless Legs Syndrome Market Size by Product (2019-2025) (Million US$) Figure Global Restless Legs Syndrome Market Size by Product (2019-2025) Figure Global Restless Legs Syndrome Market Size by Product in 2025 Table Global Restless Legs Syndrome Market Size by Application (2019-2025) (Million US$) Figure Global Restless Legs Syndrome Market Size by Application (2019-2025) Figure Global Restless Legs Syndrome Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

GlaxoSmithKline plc. Ligand Pharmaceuticals Incorporated axxonis Pharma AG Kyowa Hakko Kirin Jazz Pharmaceuticals Omeros Corporation Manhattan Pharmaceuticals Boehringer Ingelheim GmbH UCB SA